|Bid||1.0200 x 0|
|Ask||1.0500 x 0|
|Day's Range||0.9900 - 1.0900|
|52 Week Range||0.3800 - 1.5500|
|Beta (5Y Monthly)||1.20|
|PE Ratio (TTM)||3.67|
|Earnings Date||Nov. 13, 2020|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||1.23|
OAKVILLE, ON, Jan. 15, 2021 /CNW/ - Cipher Pharmaceuticals Inc.
TORONTO, Nov. 24, 2020 /CNW/ - Heart & Stroke is pleased to announce the appointment of Alison Twiner as Chair of its National Board of Directors.
Revenue Increases Sequentially to $4.9 million EBITDA2 was $2.